You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 Google Custom Search

Quad Pill

Gilead and Tibotec To Develop New Combo Pill
7-5-2011

Gilead Quad Pill Works as Well As Atripla
4-4-2011

Gilead Will Extend Phase 3 Elvitegravir Trial to 96 Weeks
1-18-2011

Elvitegravir "Quad" Single-tablet Regimen Shows Continued HIV Suppression at 48 Weeks
9-14-2010

Gilead's Quad Pill Matches Atripla, New Booster Cobicistat (GS 9350) Looks Good with Atazanavir (Reyataz)
2-19-2010

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children